These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2127055)

  • 21. Protection of the immature myocardium during ischemic arrest: dose dependent effects of glucose and mannitol when added to St Thomas' cardioplegic solution.
    Yang SS; Hearse DJ
    Can J Cardiol; 1989; 5(8):401-7. PubMed ID: 2514036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection of the immature myocardium during global ischemia. A comparison of four clinical cardioplegic solutions in the rabbit heart.
    Kempsford RD; Hearse DJ
    J Thorac Cardiovasc Surg; 1989 Jun; 97(6):856-63. PubMed ID: 2498580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of UW solution and St. Thomas' solution in the rat: importance of potassium concentration.
    Rosenfeldt FL; Conyers RA; Jablonski P; Langley L; Richards SM; Self G; Marshall V
    Ann Thorac Surg; 1996 Feb; 61(2):576-84. PubMed ID: 8572770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-related changes in the ability of hypothermia and cardioplegia to protect ischemic rabbit myocardium.
    Baker JE; Boerboom LE; Olinger GN
    J Thorac Cardiovasc Surg; 1988 Nov; 96(5):717-24. PubMed ID: 3184966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The optimal glucose concentration for intermittent cardioplegia in isolated rat heart when added to St. Thomas' Hospital cardioplegic solution.
    Owen P; du Toit EF; Opie LH
    J Thorac Cardiovasc Surg; 1993 Jun; 105(6):995-1006. PubMed ID: 8501949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal myocardial protection during crystalloid cardioplegia. Interrelationship between volume and duration of infusion.
    Takahashi A; Chambers DJ; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1988 Nov; 96(5):730-40. PubMed ID: 3184967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Superior protective effect of low-calcium, magnesium-free potassium cardioplegic solution on ischemic myocardium. Clinical study in comparison with St. Thomas' Hospital solution.
    Kinoshita K; Oe M; Tokunaga K
    J Thorac Cardiovasc Surg; 1991 Apr; 101(4):695-702. PubMed ID: 2008108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional recovery of hearts after cardioplegia and storage in University of Wisconsin and in St. Thomas' Hospital solutions.
    Choong YS; Gavin JB
    J Heart Lung Transplant; 1991; 10(4):537-46. PubMed ID: 1911796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of intramyocardial pH on functional recovery in neonatal hearts receiving St. Thomas' Hospital cardioplegic solution during global ischemia.
    Iannettoni MD; Bove EL; Fox MH; Groh MA; Bolling SF; Gallagher KP
    J Thorac Cardiovasc Surg; 1992 Aug; 104(2):333-43. PubMed ID: 1495295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term hypothermic storage of the mammalian heart for transplantation: a comparison of three cardioplegic solutions.
    Galiñanes M; Murashita T; Hearse DJ
    J Heart Lung Transplant; 1992; 11(4 Pt 1):624-35. PubMed ID: 1498125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transient hypocalcemic reperfusion does not improve postischemic recovery in the rat heart after preservation with St. Thomas' Hospital cardioplegic solution.
    Chambers DJ; Harvey DM; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1992 Aug; 104(2):344-56. PubMed ID: 1495296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The St. Thomas' hospital cardioplegic solution: a characterization in two species.
    Jynge P; Hearse DJ; Feuvray D; Mahalu W; Canković-Darracott S; O'Brien K; Braimbridge MV
    Scand J Thorac Cardiovasc Surg Suppl; 1981; 30():1-28. PubMed ID: 6278581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of cardioplegic solutions on coronary artery and myocardium--comparison of the glucose-insulin-potassium solution and the St. Thomas' Hospital cardioplegic solution].
    Watanabe H; Yokosawa T; Eguchi S; Imai S
    Nihon Kyobu Geka Gakkai Zasshi; 1989 Oct; 37(10):2142-9. PubMed ID: 2685132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Superior qualities of University of Wisconsin solution for ex vivo preservation of the pig heart.
    Mankad PS; Severs NJ; Lachno DR; Rothery S; Yacoub MH
    J Thorac Cardiovasc Surg; 1992 Aug; 104(2):229-40. PubMed ID: 1495284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effects of oxygenated St. Thomas' Hospital cardioplegic solution during ischaemic cardiac arrest: improved function, metabolism and ultrastructure.
    Choong YS; Cottier DS; Edgar SG
    J Cardiovasc Surg (Torino); 1993 Oct; 34(5):423-33. PubMed ID: 8282749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium antagonists and myocardial protection: a comparative study of the functional, metabolic and electrical consequences of verapamil and nifedipine as additives to the St. Thomas' cardioplegic solution.
    Yamamoto F; Manning AS; Crome R; Braimbridge MV; Hearse DJ
    Thorac Cardiovasc Surg; 1985 Dec; 33(6):354-9. PubMed ID: 2417372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The experimental study of myocardial protection for warm myocardial ischemia in an isolated rat heart: the effect of a calcium antagonist].
    Fukuhiro Y
    Nihon Kyobu Geka Gakkai Zasshi; 1996 Feb; 44(2):130-7. PubMed ID: 8717259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of amino acids on the ischemic heart. Improvement of oxygenated crystalloid cardioplegic solution by an enriched branched chain amino acid formulation.
    Schwalb H; Izhar U; Yaroslavsky E; Borman JB; Uretzky G
    J Thorac Cardiovasc Surg; 1989 Oct; 98(4):551-6. PubMed ID: 2796362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of continuous perfusion with St. Thomas' Hospital cardioplegic solution containing glucose, insulin and L-aspartate on functional recovery after myocardial preservation in the rat].
    Shimada Y; Yamamoto F; Yamamoto H; Kumada Y; Kagisaki K; Ishikawa T; Oka T; Kawashima Y
    Nihon Kyobu Geka Gakkai Zasshi; 1996 Sep; 44(9):1742-8. PubMed ID: 8911048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of supplementing hypothermic crystalloid cardioplegic solution with catalase, superoxide dismutase, allopurinol, or deferoxamine on functional recovery of globally ischemic and reperfused isolated hearts.
    Myers CL; Weiss SJ; Kirsh MM; Shepard BM; Shlafer M
    J Thorac Cardiovasc Surg; 1986 Feb; 91(2):281-9. PubMed ID: 3945095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.